EUVIMEDEUVIMED entdecken
Crossref

Autoantibodies in laryngeal cancer: detection and role as a biomarker

Thashani Gunasekera, Umapriyatharshini Rajagopalan, Samith Herath, Sameera Samarakoon, Rizny Sakkaff, Roshan Jalaldeen

Laboratory Medicine · 2024

DOI: 10.1093/labmed/lmad117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laboratory Medicine, 2024. Verfasst von Thashani Gunasekera und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology and Environment Sciences, Faculty of Science, University of Colombo, Sri Lanka. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Autoantibodies, Biomarkers, Tumor, Enzyme-Linked Immunosorbent Assay. Die Arbeit nennt 44 Literaturangaben. Gefördert von: University of Colombo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Diagnostic role of autoantibodies (AAb) as serological biomarkers has not been specifically investigated in laryngeal cancer (LC) previously. The study investigates the presence of anti-LC AAbs and their potential as a biomarker for early diagnosis of LC, to improve patient outcome.

Method

Anti-LC AAb levels were investigated in LC patients (n = 30) and healthy individuals (n = 30) by indirect enzyme-linked immunosorbent assay (ELISA). Patient AAb levels were analyzed with various clinical factors, primarily tumor stage.

Results

AAb levels were significantly higher in LC patients than in the control group (P = .019). The diagnostic performance of AAb-level testing for LC detection presented a sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of 70% each. The positive likelihood (LR+) and negative likelihood (LR−) ratios were 2.33 and 0.43, respectively. AAb levels were independent of cancer stage (P = .708), duration since first appearance of symptoms (P = .228), duration of medical attention (P = .231), and degree of risk-factor exposure (P = .478).

Conclusion

Significant level of AAbs could be detected among LC patients with good diagnostic performance, irrespective of stage. Thus, anti-LC AAbs reflect potential to be utilized as predictive biomarkers in early diagnostics of LC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngeal NeoplasmsAutoantibodiesBiomarkers, TumorEnzyme-Linked Immunosorbent AssayHumansMaleMiddle AgedFemaleAgedSensitivity and SpecificityAdult

Stichwörter der Autor:innen

ELISAautoantibodiesdiagnosticshead and neck cancerlaryngeal cancerserological biomarkertumor immunology

Substanzen

AutoantibodiesBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Zoology and Environment Sciences, Faculty of Science, University of Colombo, Sri Lanka.
  • Institute of Biochemistry, Molecular Biology and Biotechnology, University of Colombo, Sri Lanka.
  • ENT/Head and Neck Cancer, District General Hospital Chilaw, Chilaw, Sri Lanka.

Förderung

  • University of Colombo

Zitieren

APA

Gunasekera, T., Rajagopalan, U., Herath, S., Samarakoon, S., Sakkaff, R., & Jalaldeen, R. (2024). Autoantibodies in laryngeal cancer: detection and role as a biomarker. Laboratory Medicine. https://doi.org/10.1093/labmed/lmad117

Vancouver

Gunasekera T, Rajagopalan U, Herath S, Samarakoon S, Sakkaff R, Jalaldeen R. Autoantibodies in laryngeal cancer: detection and role as a biomarker. Laboratory Medicine. 2024. doi:10.1093/labmed/lmad117

BibTeX
@article{Gunasekera2024,
  author = {Gunasekera, Thashani and Rajagopalan, Umapriyatharshini and Herath, Samith and Samarakoon, Sameera and Sakkaff, Rizny and Jalaldeen, Roshan},
  title = {Autoantibodies in laryngeal cancer: detection and role as a biomarker},
  journal = {Laboratory Medicine},
  year = {2024},
  doi = {10.1093/labmed/lmad117}
}
Kostenlos starten →